ArticleCost effectiveness and resource allocation : C/E2026
Real-world cost avoidance associated with bevacizumab biosimilar adoption in a tertiary public hospital in Ecuador: a cost-minimization and budget impact analysis.
Sara Rodríguez et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.